“When we acquired Diapath, our vision was clear: to expand access to the most innovative histology instrumentation worldwide,” StatLab CEO Dae Hong said.
StatLab's launch of its new PiSmart S1 single-hopper slide printer for pathology labs follows the company's August acquisitions of Germany-based Histoserve GmbH and Diapath France SAS.
StatLab said its 2022 acquisition of Wales-based CellPath Ltd.—known for injection molding manufacturing of histology supplies—served as a catalyst for its new, 35,000-square-foot facility in Arlington.
North Texas’ growing venture capital community was on full display Thursday at Old Parkland, as an estimated 450 company founders, investors and other community leaders gathered for the sixth annual Venture Dallas conference....
North Texas’ growing venture capital community was on full display Thursday at Old Parkland, as an estimated 450 company founders, investors and other community leaders gathered for the sixth annual Venture Dallas conference....